Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-06-21
2011-06-21
Seaman, D. Margaret (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C514S312000, C514S313000
Reexamination Certificate
active
07964733
ABSTRACT:
Compounds of Formula Iwherein R1, A, R2, R3, R4, R5, n, m and q are as described in the specification, pharmaceutically-acceptable salts, methods of making, pharmaceutical compositions containing and methods for using the same.
REFERENCES:
patent: 5811553 (1998-09-01), Farina et al.
patent: 6335448 (2002-01-01), Sisko et al.
patent: 6355654 (2002-03-01), Giardina et al.
patent: 6432977 (2002-08-01), Giardina et al.
patent: 6608083 (2003-08-01), Farina et al.
patent: 7482458 (2009-01-01), Farina et al.
patent: 2005/0096316 (2005-05-01), Farina et al.
patent: 2008/0234269 (2008-09-01), Campbell et al.
patent: 2008/0306110 (2008-12-01), Albert et al.
patent: 0940391 (1999-09-01), None
patent: 2302689 (1997-01-01), None
patent: 9532948 (1995-12-01), None
patent: 9602509 (1996-02-01), None
patent: 9624582 (1996-08-01), None
patent: 9719926 (1997-06-01), None
patent: 9721680 (1997-06-01), None
patent: 9852942 (1998-11-01), None
patent: 0031037 (2000-06-01), None
patent: 0064877 (2000-11-01), None
patent: 0238548 (2002-05-01), None
patent: 0243734 (2002-06-01), None
patent: 0244165 (2002-06-01), None
patent: 02083645 (2002-10-01), None
patent: 02083663 (2002-10-01), None
patent: 2005014575 (2005-02-01), None
patent: 2006050989 (2006-05-01), None
patent: 2006050991 (2006-05-01), None
patent: 2006050992 (2006-05-01), None
patent: 2006137789 (2006-12-01), None
patent: 2007039123 (2007-04-01), None
patent: 2007044251 (2007-04-01), None
Guiseppe A. M. Giardina, et al, “Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 2. Identification of (S)-N-(1-phenylpropyl)-3-hydroxy-2-phenylquinoline-4-carbosamide (SB 223412)”, J. Med. Chem., 1999, 42, pp. 1053-1065.
Frank E. Blaney, et al, “Stepwise Modulation of Neurokinin-3 and Neurokinin-2 Receptor Affinity and Selectivity in Quinoline Tachykinin Receptor Antagonists”, J. Med. Chem. 2001, vol. 44, pp. 1675-1689, scheme 1 and table 1.
Stanislaw Biniecki, et al; “Synteza Beta-Fenyloetyloamidu oraz 2-I 3-Pikoliloamidow Kvasu 2-Fenylocynchoninowego”; Acta Poloniae Pharmaceutica, No. 3, vol. 34, 1977, pp. 271-273.
Albert Jeffrey S.
Alhambra Cristobal
Kang James
Koether Gerard M.
Li Yan
Astrazeneca AB
Connolly Bove & Lodge & Hutz LLP
Seaman D. Margaret
LandOfFree
Alkyl sulfoxide quinolines as NK-3 receptor ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alkyl sulfoxide quinolines as NK-3 receptor ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alkyl sulfoxide quinolines as NK-3 receptor ligands will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2738897